Milestone Pharmaceuticals Inc.
MIST
$1.32
$0.000.00%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | 0.00 | 0.00 | 0.00 | 1.00M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | 0.00 | 0.00 | 0.00 | 1.00M |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | 0.00 | 0.00 | 0.00 | 1.00M |
| SG&A Expenses | 27.75M | 27.69M | 30.67M | 31.64M | 31.05M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 42.10M | 43.55M | 49.30M | 56.07M | 62.10M |
| Operating Income | -42.10M | -43.55M | -49.30M | -56.07M | -61.10M |
| Income Before Tax | -41.52M | -42.77M | -48.41M | -55.09M | -59.69M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -41.52 | -42.77 | -48.41 | -55.09 | -59.69 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -41.52M | -42.77M | -48.41M | -55.09M | -59.69M |
| EBIT | -42.10M | -43.55M | -49.30M | -56.07M | -61.10M |
| EBITDA | -42.00M | -43.45M | -49.19M | -55.97M | -61.01M |
| EPS Basic | -0.68 | -0.81 | -1.01 | -1.25 | -1.39 |
| Normalized Basic EPS | -0.42 | -0.50 | -0.63 | -0.78 | -0.87 |
| EPS Diluted | -0.68 | -0.81 | -1.01 | -1.25 | -1.39 |
| Normalized Diluted EPS | -0.42 | -0.50 | -0.63 | -0.78 | -0.87 |
| Average Basic Shares Outstanding | 248.78M | 225.57M | 202.36M | 179.13M | 171.82M |
| Average Diluted Shares Outstanding | 248.78M | 225.57M | 202.36M | 179.13M | 171.82M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |